Thursday, January 14, 2010

Basis Ventures

My novel Vulture Capital is about a fictional venture capital firm called Basis Ventures and the deadly shenanigans that go on there. (Think of The Firm, but with VCs in place of lawyers, and perverse applications of biotechnology in place of connections to the mob.)

Although the book has been out for a while, I thought it might be fun to throw up a website for Basis Ventures, including all the partners with their bios and short descriptions of the portfolio companies in which they've invested.

You can find it here.

I used royalty-free stock photos for the pictures of the individual partners, and I had a lot of fun trying to match my descriptions from the book to the available photos from stock photography sites. The photo featured at the top of this post is the one I selected for Larry Breen, co-founder and Managing Partner of Basis Ventures.

Coming up with the names and logos of the portfolio companies was nearly as much fun. I used a name-generator service and royalty-free logos I found on the web for many of them. For their product and service descriptions, I tried to pick hot technology areas and then gin up offerings that seemed consistent with what was already being done in the space--or jump ahead a bit to suggest entirely new capabilities or technologies. For example, in the category of start-ups with offerings consistent with the current state of the art, the company Mizu purports to be the leading SaaS platform for mobile phone applications.

Of course the most important portfolio company is the one described in the book: NeuroStimix. As the Basis Ventures site describes, NeuroStimix develops neurostimulation devices to restore mobility to spinal cord injury victims. The technology from NeuroStimix is definitely pushing the envelope of what's possible now, but check out Neurostream for an example of a company offering products in this area right now.

If all this has whet your appetite for the book, you might also check out this review of it on Salon.com.

0 Comments:

Post a Comment

<< Home